ArticlePharmacoEconomics2022

Factors Limiting Subgroup Analysis in Cost-Effectiveness Analysis and a Call for Transparency.

Gemma E Shields et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.